Standard Biotools Stock Price History
| LAB Stock | USD 1.82 0.11 6.43% |
Below is the normalized historical share price chart for Standard Biotools extending back to February 10, 2011. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Standard Biotools stands at 1.82, as last reported on the 28th of November, with the highest price reaching 1.87 and the lowest price hitting 1.71 during the day.
If you're considering investing in Standard Stock, it is important to understand the factors that can impact its price. Standard Biotools owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0397, which indicates the firm had a -0.0397% return per unit of risk over the last 3 months. Standard Biotools exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Standard Biotools' Risk Adjusted Performance of (0.05), coefficient of variation of (1,429), and Variance of 16.05 to confirm the risk estimate we provide.
At present, Standard Biotools' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 83.1 M, whereas Liabilities And Stockholders Equity is forecasted to decline to about 228.8 M. . At present, Standard Biotools' Price Book Value Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 2.08, whereas Price To Sales Ratio is forecasted to decline to 1.56. Standard Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of July 2003 | 200 Day MA 2.1854 | 50 Day MA 1.8644 | Beta 1.569 |
Standard |
Sharpe Ratio = -0.0397
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LAB |
Estimated Market Risk
| 4.14 actual daily | 36 64% of assets are more volatile |
Expected Return
| -0.16 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Standard Biotools is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Standard Biotools by adding Standard Biotools to a well-diversified portfolio.
Price Book 1.3009 | Enterprise Value Ebitda (19.22) | Price Sales 4.0831 | Shares Float 48.8 M | Wall Street Target Price 3.0833 |
Standard Biotools Stock Price History Chart
There are several ways to analyze Standard Stock price data. The simplest method is using a basic Standard candlestick price chart, which shows Standard Biotools price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 6, 2024 | 2.26 |
| Lowest Price | November 18, 2024 | 1.5 |
Standard Biotools November 28, 2024 Stock Price Synopsis
Various analyses of Standard Biotools' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Standard Stock. It can be used to describe the percentage change in the price of Standard Biotools from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Standard Stock.| Standard Biotools Price Action Indicator | 0.09 | |
| Standard Biotools Accumulation Distribution | 147,094 | |
| Standard Biotools Price Rate Of Daily Change | 1.06 | |
| Standard Biotools Price Daily Balance Of Power | 0.69 |
Standard Biotools November 28, 2024 Stock Price Analysis
Standard Stock Price History Data
The price series of Standard Biotools for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 0.76 with a coefficient of variation of 9.3. The daily prices for the period are spread out with arithmetic mean of 1.9. The median price for the last 90 days is 1.9. The company underwent null stock split on 6th of December 2001.| Open | High | Low | Close | Volume | ||
| 11/27/2024 | 1.71 | 1.87 | 1.71 | 1.82 | 1,719,160 | |
| 11/26/2024 | 1.61 | 1.72 | 1.58 | 1.71 | 2,129,014 | |
| 11/25/2024 | 1.63 | 1.65 | 1.59 | 1.62 | 1,614,302 | |
| 11/22/2024 | 1.65 | 1.67 | 1.58 | 1.60 | 1,424,106 | |
| 11/21/2024 | 1.62 | 1.67 | 1.56 | 1.62 | 1,958,048 | |
| 11/20/2024 | 1.51 | 1.69 | 1.48 | 1.61 | 3,163,750 | |
| 11/19/2024 | 1.49 | 1.56 | 1.46 | 1.51 | 3,307,376 | |
| 11/18/2024 | 1.57 | 1.58 | 1.48 | 1.50 | 2,360,060 | |
| 11/15/2024 | 1.72 | 1.73 | 1.57 | 1.58 | 2,355,984 | |
| 11/14/2024 | 1.81 | 1.84 | 1.67 | 1.70 | 1,985,678 | |
| 11/13/2024 | 2.07 | 2.10 | 1.84 | 1.84 | 2,205,184 | |
| 11/12/2024 | 2.20 | 2.22 | 2.03 | 2.05 | 3,183,741 | |
| 11/11/2024 | 2.21 | 2.26 | 2.13 | 2.23 | 1,620,544 | |
| 11/08/2024 | 2.18 | 2.21 | 2.12 | 2.15 | 1,459,272 | |
| 11/07/2024 | 2.25 | 2.32 | 2.16 | 2.18 | 2,319,568 | |
| 11/06/2024 | 2.24 | 2.27 | 2.10 | 2.26 | 3,325,249 | |
| 11/05/2024 | 2.08 | 2.23 | 2.06 | 2.11 | 3,576,420 | |
| 11/04/2024 | 2.00 | 2.11 | 1.99 | 2.10 | 2,573,184 | |
| 11/01/2024 | 1.96 | 2.12 | 1.96 | 1.99 | 2,514,044 | |
| 10/31/2024 | 1.98 | 2.26 | 1.93 | 1.96 | 4,634,765 | |
| 10/30/2024 | 1.74 | 1.92 | 1.72 | 1.88 | 5,510,274 | |
| 10/29/2024 | 1.70 | 1.82 | 1.69 | 1.75 | 3,935,921 | |
| 10/28/2024 | 1.70 | 1.76 | 1.67 | 1.70 | 2,592,250 | |
| 10/25/2024 | 1.74 | 1.74 | 1.66 | 1.68 | 1,545,365 | |
| 10/24/2024 | 1.82 | 1.84 | 1.72 | 1.73 | 913,430 | |
| 10/23/2024 | 1.81 | 1.85 | 1.78 | 1.78 | 2,419,038 | |
| 10/22/2024 | 1.90 | 1.90 | 1.81 | 1.84 | 982,275 | |
| 10/21/2024 | 1.90 | 1.91 | 1.85 | 1.88 | 848,965 | |
| 10/18/2024 | 1.79 | 1.91 | 1.79 | 1.90 | 954,658 | |
| 10/17/2024 | 1.88 | 1.90 | 1.78 | 1.80 | 664,342 | |
| 10/16/2024 | 1.92 | 1.92 | 1.85 | 1.89 | 1,105,417 | |
| 10/15/2024 | 1.87 | 1.92 | 1.86 | 1.89 | 963,592 | |
| 10/14/2024 | 1.85 | 1.90 | 1.80 | 1.89 | 922,876 | |
| 10/11/2024 | 1.77 | 1.90 | 1.77 | 1.89 | 1,428,245 | |
| 10/10/2024 | 1.74 | 1.78 | 1.69 | 1.77 | 1,380,185 | |
| 10/09/2024 | 1.79 | 1.80 | 1.73 | 1.77 | 1,139,582 | |
| 10/08/2024 | 1.81 | 1.87 | 1.78 | 1.80 | 886,444 | |
| 10/07/2024 | 1.83 | 1.87 | 1.81 | 1.82 | 1,519,983 | |
| 10/04/2024 | 1.86 | 1.88 | 1.82 | 1.85 | 594,857 | |
| 10/03/2024 | 1.83 | 1.85 | 1.80 | 1.81 | 558,612 | |
| 10/02/2024 | 1.86 | 1.88 | 1.79 | 1.86 | 1,236,290 | |
| 10/01/2024 | 1.91 | 1.92 | 1.83 | 1.86 | 1,182,198 | |
| 09/30/2024 | 1.91 | 1.95 | 1.86 | 1.93 | 927,798 | |
| 09/27/2024 | 1.93 | 1.95 | 1.90 | 1.92 | 885,116 | |
| 09/26/2024 | 1.88 | 1.91 | 1.82 | 1.90 | 1,581,242 | |
| 09/25/2024 | 1.97 | 1.99 | 1.82 | 1.83 | 1,493,101 | |
| 09/24/2024 | 1.89 | 1.98 | 1.87 | 1.97 | 1,558,451 | |
| 09/23/2024 | 2.00 | 2.00 | 1.86 | 1.87 | 1,308,754 | |
| 09/20/2024 | 2.08 | 2.08 | 1.99 | 2.01 | 4,829,565 | |
| 09/19/2024 | 2.12 | 2.15 | 2.06 | 2.11 | 1,158,441 | |
| 09/18/2024 | 1.95 | 2.15 | 1.92 | 2.03 | 1,322,425 | |
| 09/17/2024 | 2.08 | 2.12 | 1.97 | 2.00 | 1,385,705 | |
| 09/16/2024 | 2.06 | 2.09 | 2.00 | 2.09 | 1,021,135 | |
| 09/13/2024 | 2.07 | 2.17 | 2.03 | 2.06 | 1,266,985 | |
| 09/12/2024 | 2.02 | 2.05 | 1.94 | 2.03 | 1,117,689 | |
| 09/11/2024 | 1.98 | 2.00 | 1.92 | 1.98 | 1,687,830 | |
| 09/10/2024 | 1.99 | 2.02 | 1.87 | 2.00 | 1,349,685 | |
| 09/09/2024 | 1.90 | 2.07 | 1.89 | 1.99 | 2,930,932 | |
| 09/06/2024 | 1.93 | 2.01 | 1.89 | 1.94 | 1,396,937 | |
| 09/05/2024 | 1.94 | 2.00 | 1.89 | 1.96 | 782,413 | |
| 09/04/2024 | 1.96 | 2.01 | 1.88 | 1.93 | 1,193,520 |
About Standard Biotools Stock history
Standard Biotools investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Standard is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Standard Biotools will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Standard Biotools stock prices may prove useful in developing a viable investing in Standard Biotools
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 79.2 M | 83.1 M | |
| Net Loss | -171.1 M | -162.5 M |
Standard Biotools Quarterly Net Working Capital |
|
Standard Biotools Stock Technical Analysis
Standard Biotools technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Standard Biotools Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Standard Biotools' price direction in advance. Along with the technical and fundamental analysis of Standard Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Standard to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.57) | |||
| Total Risk Alpha | (0.92) | |||
| Treynor Ratio | (0.12) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Standard Stock analysis
When running Standard Biotools' price analysis, check to measure Standard Biotools' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Standard Biotools is operating at the current time. Most of Standard Biotools' value examination focuses on studying past and present price action to predict the probability of Standard Biotools' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Standard Biotools' price. Additionally, you may evaluate how the addition of Standard Biotools to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |